...BRCA1 promoter region in peripheral blood DNA. We calculated standardised incidence ratios (SIR) by comparing the number...
...BRCA1) as a new predictive marker for chemotherapy and radiotherapy of NSCLC.
...BRCA1 and BRCA2 mutation carriers and could also be helpful in understanding how BRCA1 and BRCA2 genes are involved in B...
...BRCA1 (P = 0.010) and BRCA2 (P < 0.001). The most frequently hypermethylated genes (MSH6, CDH13, PAX5, PAX6 and WT1) wer...
A recent prospective clinical trial provides further evidence that breast cancers arising in germline BRCA1 mutation car...
...BRCA1 amplification. With respect to both compounds, the inhibition of BRCA1 amplification is more effective in an isola...
...BRCA1 has been found to exhibit a hormone-dependent pattern of expression in breast cells. Wild-type BRCA1 is required f...
...BRCA1/2 mutation negative).,Models developed using extended family history and genetic data, such as the IBIS model, als...
...BRCA1 mutations, in the context of multiple predictive factors.,Germline mutations in BRCA1 and BRCA2 were analyzed by S...
Many cancer-patients undergo DNA testing in the BRCA1/2 genes to receive information about the likelihood that cancer is...
联系地址
山东省济南市章丘区文博路2号
齐鲁师范学院 genelibs生信实验室
山东省济南市高新区舜华路750号
大学科技园北区F座4单元2楼
电话： 0531-88819269
版权所有 © 2025.Genelibs 济南弘晖生物技术有限公司 鲁ICP备20007159号-2
